Skip to content
Use caution Drug recall · FDA · Published October 17, 2014

Northstar Rx Gabapentin Recall: Empty Capsule Complaints

Northstar Rx recalls 24,816 bottles of Gabapentin 300 mg capsules due to complaints of empty capsules. Check your lot number GESB14011-A.

🇺🇸 FDA recall #D-0330-2015DrugNorthstar Rx ›
Take action

Contact the company

Recalling firmAurobindo Pharma USA Inc6 Wheeling Road · Dayton, NJ 08810
✎ GovInfoNow plain-language explainer

Northstar Rx LLC has recalled specific bottles of Gabapentin Capsules, USP 300 mg because consumers complained of receiving empty capsules. The recall affects 24,816 bottles distributed nationwide. This issue relates to failed tablet and capsule specifications rather than a chemical defect in the drug itself. Read more at govinfonow.com/recall/45649-aurobindo-pharma-usa-inc-recalls-gabapentin-capsules-usp-300-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/45649-aurobindo-pharma-usa-inc-recalls-gabapentin-capsules-usp-300-mg · Updated October 12, 2026 · FDA enforcement record: FDA #D-0330-2015

Cite this page

“Northstar Rx Gabapentin Recall: Empty Capsule Complaints.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45649-aurobindo-pharma-usa-inc-recalls-gabapentin-capsules-usp-300-mg. Based on FDA recall #D-0330-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0330-2015%22&limit=1).

Aurobindo Pharma USA Inc, on behalf of Northstar Rx LLC, recalled Gabapentin Capsules USP 300 mg due to failed specifications involving empty capsules, according to the FDA. The Food and Drug Administration announced the recall on Oct. 17, 2014.

How to tell if you have it

  • Northstar Rx
  • Gabapentin Capsules, USP 300 mg, 100-count bottles
  • NDC 16714-662-01
  • UPC 3 16714-662-01 5
  • Lot #: GESB14011-A
  • Exp 12/15

The hazard

The recall addresses complaints of empty capsules received by consumers. The product failed tablet and capsule specifications.

Context

GovInfoNow's records show Aurobindo Pharma USA Inc has 32 other recalls on record since April 9, 2013. Other recent recalls include a July 23, 2026 recall of Dicyclomine Capsules due to empty capsules and a May 22, 2025 recall of Acetaminophen Tablets for brown tablet discoloration risk. Northstar Rx also issued a Sept. 25, 2026 recall for Tretinoin Cream due to impurities.

How to tell if you have this one

Look for 100-count bottles of Gabapentin Capsules, USP 300 mg manufactured by Aurobindo Pharma Limited for Northstar Rx LLC. Check the label for NDC 16714-662-01, UPC 3 16714-662-01 5, and Lot # GESB14011-A with an expiration date of 12/15.

  • Brand
    Northstar Rx
  • Product
    Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication

    Verify if you have bottles matching the recalled lot number GESB14011-A and NDC 16714-662-01.

  2. Contact your pharmacist

    Inform your pharmacy or healthcare provider if you have the recalled product to discuss replacement options.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Oct 17, 201412. FDA classified it Class II: Jan 6, 201523. Published in FDA’s Enforcement Report: Jan 14, 201534. FDA terminated the recall: May 23, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How many bottles are being recalled?

A total of 24,816 bottles are included in this recall.

Where was this product sold?

The product was distributed nationwide across the United States.

Similar recalls

Other Northstar Rx recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0330-2015 (October 17, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0330-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA